Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

FDA clears Roche automated herpes simplex virus type 1 and 2 tests

The US Food and Drug Administration (FDA) has granted clearance to Roche's automated Elecsys HSV-1 IgG and HSV-2 IgG assays, designed for the determination of IgG class antibodies to HSV-1 and HSV-2 in human serum or plasma of sexually active individuals and expectant mothers.

The assays are desgined for use on the company’s cobas e 411, cobas e 601, cobas e 602 and Modular Analytics E170 analyzers.

The company said the immunoassays are intended for use with its electrochemiluminescence technology, a light detection system that provides low-end sensitivity and broad dynamic measuring ranges.

Roche Diagnostics marketing vice president Randy Pritchard said the automated type-specific herpes tests will enable labs to integrate efficient herpes testing into their existing workflow.

"The approval of the type-specific assays also means healthcare providers now have another tool to give them greater confidence in their diagnosis and overall patient care," Pritchard added.